Position in ICLR
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$241,456
New position
Shares Held
1,390
first reported quarter
Ownership
0.002%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#293
of 422 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Essex Financial Services, Inc. holds $8,380,568 across 10 Diagnostics & Research names. ICLR ranks #9 (2.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
7,677 | $3,848,940 | |
| 2 | DHR |
Danaher Corp /De/
|
5,333 | $1,015,829 | |
| 3 | IDXX |
Idexx Laboratories Inc /De
|
1,565 | $823,878 | |
| 4 | LH |
Labcorp Holdings Inc.
|
2,248 | $629,440 | |
| 5 | DGX |
Quest Diagnostics Inc
|
2,653 | $562,303 | |
| 6 | NTRA |
Natera, Inc.
|
1,673 | $454,135 | |
| 7 | ILMN |
Illumina, Inc.
|
1,716 | $301,724 | |
| 8 | WAT |
Waters Corp /De/
|
732 | $274,529 |
All Filings in ICLR
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $241,456 | 1,390 | Shares | Sole | 2026-08-10 | |
| No filing history on record for this holder in this stock. | ||||||